STARTUPS ARE DEVELOPING TECHNOLOGIES
TO OVERCOME THE CORONAVIRUS CRISIS

Startups are making a meaningful difference in how we confront viral outbreaks - developing medical innovations, social distancing technologies, lifestyle and business continuity tools and more.

CREATE A FREE ACCOUNT
OurCrowd is the leading venture investor in Israel, investing in startups and venture funds alongside renowned VCs and institutional investors. Currently, the main focus is companies addressing health emergencies across a variety of sectors - including digital medicine, diagnostics, cybersecurity, and remote learning, and enterprise solutions.


Browse a selection of startups in these categories: 

Providing rapid and accurate blood tests to aid health professionals in diagnosing and treating patients at the point of care.

“If anything kills over 10 million people in the next few decades, it’s most likely to be a highly infectious virus rather than a war – not missiles, but microbes. Part of the reason is we have invested a huge amount in nuclear deterrents, but we’ve actually invested very little in a system to stop an epidemic.”

-Bill Gates

 

Distinguishes within two hours whether an illness is viral or bacterial to help officials detect people infected before any symptoms appear.

CREATE A FREE ACCOUNTLearn About MigVaxLearn About MeMedLearn About Sight DX

INVEST IN 3 EASY STEPS

Join the OurCrowd platform, create a FREE investor account (accredited investors only). 

Browse investment opportunities, review due diligence material.

Invest and receive quarterly updates on your portfolio’s progress.

Developing a safe oral coronavirus vaccine, leveraging a licensed platform technology developed over the past four years.

1 | JOIN

2 | BROWSE

3 | INVEST

CREATE A FREE ACCOUNT

$1.4B

COMMITTED

FUNDS 

PORTFOLIO 

COMPANIES


200

COMPANIES 

VETTED 

10,000

22

FUNDS 

COUNTRIES

 REPRESENTED 

183

41,000

REGISTERED 

INVESTORS 

OurCrowd is a global venture investing platform that empowers institutions and individuals to invest and engage in emerging companies. The most active venture investor in Israel, OurCrowd vets and selects companies, invests its capital, and provides its global network with unparalleled access to co-invest and contribute connections, talent and deal flow. OurCrowd builds value for its portfolio companies throughout their lifecycles, providing mentorship, recruiting industry advisors, navigating follow-on rounds and creating growth opportunities through its network of multinational partnerships.  

With $1.4 billion of committed funding, and investments in 200 portfolio companies and 22 venture funds, OurCrowd offers access to its membership of 41,000 individual accredited and institutional investors, family offices, and venture capital partners from over 183 countries to invest alongside, at the same terms.  OurCrowd’s portfolio is diversified across sectors and stages, ranging from seed and Series A through late stage and pre-IPO firms. Since its founding in 2013, OurCrowd portfolio companies have been acquired by some of the most prestigious brands in the world, including Uber, Canon, Oracle, Nike, and Intel.

Learn About MedisafeLearn About KemtaiLearn About ITsMine
Supporting patients with an easy-to-use, personalized medication management platform while offering healthcare companies meaningful insights.

Personalized home fitness experience, training with a virtual AI coach that can actually 'see', as if a trainer were there in the room.

Protects organizational data proactively, seamlessly and automatically, all while improving corporate compliance.

Invest in the fight against COVID-19

Access information about today's venture capital landscape and investment opportunities by creating a free account with OurCrowd.